As a leading radiotherapy department, it is our aim to improve the quality and effectiveness of our treatments through research. Worldwide, our department plays a pivotal role in novel evidence-based methodology, the model-based approach, used in the implementation and validation of new radiotherapy technologies. Key in this approach is that regular care and scientific research are maximally integrated. It is our ambition to maintain and expand this international leading role.
The menu items in the left hand column provide you more detailed information regarding our GRayLines R&D Program and its three research themes, grants and awards we have won, our scientific publications and the scientific events we (co-)organize.